Epigenomics

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Epigenomics trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 6 trials

RecruitingNot Applicable

NCT06817408

Dynamics of Organ Damage and Immune Exhaustion During Sepsis

This is a prospective, non-randomized study investigating if organ damage and immune changes can be measured by liquid biopsy NGS through advanced analytical me…

United States1,000 participantsStarted 2025-03-25

Treatment: Observation

RecruitingNot Applicable

NCT06828679

Using AI Systems to Optimize the Clinical Outcome of Stroke Patients

This project addresses the imminent challenge of providing adequate motor rehabilitation to a growing number of stroke survivors amidst the ageing population, d…

Hong Kong400 participantsStarted 2025-07-01

Treatment: Acupuncture, control group

RecruitingNot Applicable

NCT06915805

Multi-observational Study for the Early Identification of Autism Spectrum Disorder (ASD) and Other Neurodevelopmental Di…

Autism spectrum disorder (ASD) is a neurodevelopmental disorder (NDD) that affects about 78 million people worldwide. Its prevalence and degree of impact on ind…

Italy296 participantsStarted 2023-04-01

RecruitingNot Applicable

NCT06785597

EpigenOMic Determinants of the Neuroendocrine Phenotype As Biomarkers for Neuroendocrine Neoplasms

For GEP mixed neuroendocrine (NE) non-neuroendocrine neoplasms (MiNENs) a key issue affecting prognosis is sometimes the difficulty in obtaining a timely diagno…

Italy130 participantsStarted 2024-10-21

RecruitingNot Applicable

NCT05199259

Multi-analyte Blood Test Clinical Trial

The objective of this study is the acquisition of whole blood samples and serum samples from participants with untreated Hepatocellular Carcinoma (HCC) and subj…

United States1,200 participantsStarted 2022-03-01

Treatment: Multi-analyte Blood Test

RecruitingNot Applicable

NCT05307367

Cancer-associated Muscle Mass - Molecular Factors and Exercise Mechanisms

Muscle mass loss is a common adverse effect of cancer. Muscle mass loss occurs with or without reduction in body weight. Cancer cachexia (CC) is the involuntary…

Denmark144 participantsStarted 2022-04-01

Treatment: Exercise training

All recent trials (40 shown)

Not Yet RecruitingNot Applicable

NCT07562243

Project PHOENIX: Molecular Signatures of Burn Pit Exposure

Project PHOENIX is an observational clinical research study designed to characterize molecular, genomic, cellular, and functional features in blood specimens fr…

Location not specified1,000 participantsStarted 2026-05-01

Treatment: Prior Burn Pit Exposure, No Known Burn Pit Exposure

CompletedNot Applicable

NCT07436936

OPTIPROT, Targeted Precision Nutrition for Protein Needs in Ageing

This multicenter, cross-sectional observational study aims to use precision nutrition tools to identify metabolic clusters in adults aged 50-75 years, enabling…

Spain200 participantsStarted 2024-07-11

Epigenomics

Trial phase breakdown

Trial status

Actively recruiting — 6 trials

Dynamics of Organ Damage and Immune Exhaustion During Sepsis

Using AI Systems to Optimize the Clinical Outcome of Stroke Patients

Multi-observational Study for the Early Identification of Autism Spectrum Disorder (ASD) and Other Neurodevelopmental Di…

EpigenOMic Determinants of the Neuroendocrine Phenotype As Biomarkers for Neuroendocrine Neoplasms

Multi-analyte Blood Test Clinical Trial

Cancer-associated Muscle Mass - Molecular Factors and Exercise Mechanisms

All recent trials (40 shown)

Project PHOENIX: Molecular Signatures of Burn Pit Exposure

OPTIPROT, Targeted Precision Nutrition for Protein Needs in Ageing

Trial phase breakdown

Trial status

Actively recruiting — 6 trials

Dynamics of Organ Damage and Immune Exhaustion During Sepsis

Using AI Systems to Optimize the Clinical Outcome of Stroke Patients

Multi-observational Study for the Early Identification of Autism Spectrum Disorder (ASD) and Other Neurodevelopmental Di…

EpigenOMic Determinants of the Neuroendocrine Phenotype As Biomarkers for Neuroendocrine Neoplasms

Multi-analyte Blood Test Clinical Trial

Cancer-associated Muscle Mass - Molecular Factors and Exercise Mechanisms

All recent trials (40 shown)

Project PHOENIX: Molecular Signatures of Burn Pit Exposure

OPTIPROT, Targeted Precision Nutrition for Protein Needs in Ageing

National Survey to Understand Ethical, Legal and Social Issues in Communicating to the Public About Epigenetics

"A Privacy-protecting Environment for Child Transplants Health Related and Genomic Data Integration in the European Refe…

NeuroPsyBiT-BD Omics: Genomic & Epigenomic Biobank of Bipolar Disorder

PPIO-004 Clinical Application of Efficacy Prediction Model Based on Epigenomics Sequencing Technology in Neoadjuvant Imm…

Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines

A Study to Evaluate the Effect of a Topical Retinol on Epigenetic Changes and Expression of Certain Genes in the Skin Us…

MSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients with Cirrhosis

Skeletal Maturation and Endocrine Health in Young Adults

Epigenomic and Machine Learning Models to Predict Pancreatic Cancer

Analysis of the Prognostic Role of Epigenetic Biomarkers in Relation to the Motor Decline in Parkinson's Disease

The Epigenomic Signature of Eosinophilic Granulomatosis With Polyangiitis

Early Parenting Intervention: Bio-behavioral Outcomes in Infants With Neurodevelopmental Disabilities

Linking Epigenomics With Prescription Opioid Abuse and High Impact Musculoskeletal Pain

Effect of Exercise on Genes That Control Muscle Function

Epigenomic Dysregulation in Preeclampsia-Associated Chronic Hypertension

Genomic and Epigenomic Alterations After Cancer Treatment in Pregnancy

Genomics and Metagenomics of Asthma Severity

Non-invasive Liquid Biopsy Analysis of Epigenomics Signatures in Multiple Cancer Types